Research and Development
Baxter names José Almeida chairman and chief executive
October 29, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Joe Almeida, José Almeida, baxter
FDA approves first-in-class Amgen melanoma drug
October 28, 2015 Research and Development, Sales and Marketing Amgen, Imlygic, melonoma
Otsuka kidney drug earns first NICE nod
October 28, 2015 Research and Development, Sales and Marketing NHS, NICE, jinarc, kidney disease, tolvaptan
Sales up at MSD while Keytruda hits survival target in late-stage trial
October 28, 2015 Research and Development, Sales and Marketing MSD, Merck, financial results, keytruda, pembrolizumab
Otsuka, GW announce Sativex fails in Phase III cancer pain trials
October 28, 2015 Research and Development, Sales and Marketing Cancer, GX Pharmaceuticals, Otsuka, Sativex, cancer pain, palliative care, phase III, phase III failure
OPINION: ‘More work remains if biosimilars are to fulfil their potential’
October 27, 2015 Manufacturing and Production, Research and Development, Sales and Marketing British Generic Manufacturers Association, NHS, bgma, biosimilars, generics, patent cliff, patents
Pharma reaction to the Government’s AAR review
October 27, 2015 Manufacturing and Production, Research and Development Accelerated Access Review
New Phase III data puts Shire’s lifitegrast back on track for 2016 launch
October 27, 2015 Research and Development Shire, dry eye disease, lifitegrast
North of England secures new ‘centres of excellence’ in ‘precision medicine’
October 27, 2015 Manufacturing and Production, Research and Development NHS, Northern Health Science Alliance, UK
Revealed: recommendations from the Accelerated Access Review
October 27, 2015 Manufacturing and Production, Research and Development Accelarated Access Review, NHS
GSK’s Volibris gets pulmonary arterial hypertension approval in Europe
October 26, 2015 Research and Development, Sales and Marketing EMA, GSK
Puretech Health co-founder and board member Dr Robert Langer wins global engineering prize
October 26, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Dr Robert Langer, Engineering, PureTech Health, Queen Elizabeth engineering prize
Amgen skin cancer drug gets European approval
October 23, 2015 Research and Development Amgen, Imlygic, melanoma, skin cancer
Gilead presents Phase III results for Genvoya in HIV
October 22, 2015 Medical Communications, Research and Development Genvoya, Gilead Sciences, HIV
NICE recommends four treatments for arthritis in children
October 22, 2015 Medical Communications, Research and Development NICE, arthritis, jia
Latest content
MedPharm appoints Jason Mieding as chief operating officer
Coriolis Pharma appoints Teun van der Heide as CEO
